Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease

International Journal of Geriatric Psychiatry

Volumn 12, Issue 9, 1997, Pages 913-919

  Volicer, Ladislav ^a,b   Stelly, Marilyn ^c   Morris, Judith ^a   McLaughlin, Joseph ^a   Volicer, Beverly J ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

Alzheimer's disease; Anorexia; Behavior; Dronabinol

Indexed keywords

ANTIEMETIC AGENT; DRONABINOL;

AGED; ALZHEIMER DISEASE; ANOREXIA; ANXIETY; ARTICLE; ATAXIA; BEHAVIOR DISORDER; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIARRHEA; EUPHORIA; FATIGUE; FEMALE; FLUSHING; GERONTOPSYCHIATRY; HALLUCINATION; HEADACHE; HUMAN; MALE; MYALGIA; NIGHTMARE; PARANOIA; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SPEECH DISORDER; SWEATING;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANOREXIA; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; APPETITE STIMULANTS; BEHAVIORAL SYMPTOMS; CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; SEVERITY OF ILLNESS INDEX; TETRAHYDROCANNABINOL; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0030886734     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D     Document Type: Article

References (25)

1. Agurell, S., Halldin, M., Lindgren, J.-E., Ohlsson, A., Widman, M., Gillespie, H. and Hollister, L. (1986) Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol. Rev. 38, 21-43.
2. Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F. and Shepard, K. V. (1995) Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J. Pain Sympt. Manag. 10, 89-97.
3. Callahan, S. (1995) The dilemma of feeding end-stage Alzheimer patients. Am. J. Alzheim. Dis., May/June, 7-14.
4. Chiu, P., Olsen, D. M., Borys, H. K., Karler, R. and Turkanis, S. A. (1979) The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt e rats. Epilepsia 20, 365-375.
5. Cohen-Mansfield, J., Marx, M. S. and Rosenthal, A. S. (1989) A description of agitation in a nursing home. J. Gerontol. Med. Sci. 44, M77-M84.
6. Dackis, C. A., Pottash, A. L. C., Annitto, W. and Gold, M. S. (1982) Persistence of urinary marijuana levels after supervised abstinence. Am. J. Psychiat. 139, 1196-1198.
7. Devine, M. L., Greenberg, B. R., Icaza, L. et al. (1987) Adverse reactions to deIta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study. Clin. Pharm. 6, 319-322.
8. Ellis Jr, G. M., Mann, M. A., Judson, B. A., Schramm, N. T. and Tashchian, A. (1985) Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin. Pharmacol. Ther. 38, 572-578.
9. Emery, V. O. and Oxman, T. E. (1992) Update on the dementia spectrum of depression. Am. J. Psychiat. 149, 305-317.
10. Folstein, M., Folstein, S. and McHugh, P. J. (1975) 'Mini-mental State', a practical method for grading the cognitive state of patients for clinicians. J. Psychiatr. Res. 12, 189-198.
11. Gorter, R. (1991) Management of anorexia-cachexia associated with cancer and HIV infection. One. 5, Suppl, 13-17.
12. Katz, S., Ford, A. B., Moskowitz, R. W., Jackson, B. A. and Jaffe, M. W. (1963) Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 185, 914-919.
13. Lawton, M. P., DeVoe, M. R. and Parmelee, P. (1995) Relationship of events and affect in the daily life of an elderly population. Psychol. Aging 3, 469-477.
14. Lawton, M. P., Van Haitsma, K. and Klapper, J. (1996) Observed affect in nursing home residents with Alzheimer's disease. J. Gerontol. [B] 51B, P3-P14.
15. Lo, B. and Dornbrand, L. (1984) Guiding the hand that feeds: Caring for the demented elderly. N. Engl. J. Med. 311, 402-404.
16. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
17. Morley, J. E., Mooradian, A. D., Silver, A. J., Heber, D. and Alfin-Slater, R. B. (1988) Nutrition in the elderly. Ann. Intern. Med. 109, 890-904.
18. Norberg, A., Norberg, B. and Bexell, G. (1980) Ethical problems in feeding patients with advanced dementia. Brit. Med. J. 281, 847-848.
19. Regelson, W., Butler, J. R., Schultz, J., Kirk, T., Peek, L. and Green, M. L. (1976) Delta-9-tetrahydrocannabinol (delta-9-THC) as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In The Pharmacology of Marijuana (M. C. Braude and S. Szara, Eds). Raven Press, New York, pp. 763-766.
20. Sallan, S. E., Cronin, C., Zelen, M. and Zinberg, N. E. (1980) Antiemetics in patients receiving chemotherapy for cancer: A randomized comparison of delta-9tetrahydrocannabinola and prochlorperazine. N. Engl. J. Med. 302, 135-138.
21. Struwe, M., Kaempfer, S. H., Geiger, C. J., Pavia, A. T., Plasse, T. F., Shepard, K. V., Ries, K. and Evans, T. G. (1993) Effect of dronabinol on nutritional status in HIV infection. Ann. Pharmacother, 27, 827-831.
22. Volicer, L., Seltzer, B., Rheaume, Y., Karner, J., Glennon, M., Riley, M. E. and Crino, P. B. (1989) Eating difficulties in patients with probable dementia of the Alzheimer type. J. Ger. Psych. Neurol. 2, 169-176.
23. Volicer, L., Hurley, A. C., Lathi, D. C. and Kowall, N. W. (1994a) Measurement of severity in advanced Alzheimer's disease. J. Gerontol. 49, M223-M226.
24. Volicer, L., Rheaume, Y. and Cyr, D. (1994b) Treatment of depression in advanced Alzheimer's disease using sertraline. J. Ger. Psych. Neurol. 7, 227-229.
25. Volicer, L., Smith, S. and Volicer, B. J. (1995) Effect of seizures on progression of dementia of the Alzheimer type. Dementia 6, 258-263.